Insider · CIK 0001578368

Harbaugh Matthew K

Reports to the SEC for 3 companies · HAZELWOOD, MO

sec.gov

Transactions

Companies

Filings

CIK

0001578368

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-12-03	QQnity Electronics, Inc. · Stock Options (Right to Buy) NQOsA Award	Chief Financial Officer	AAward	+49.8K sh	—	—	49,807
2025-11-01	QQnity Electronics, Inc.J Other	Chief Financial Officer	JOther	+9,291.551 sh	—	—	9,291.551
2023-09-01	NUVASIVE INCPerformance Restricted Stock UnitD Disposition to Issuer	EVP and CFO	DDisposition to Issuer	−14.7K sh	—	—	0
2023-09-01	NUVASIVE INCPerformance Restricted Stock UnitD Disposition to Issuer	EVP and CFO	DDisposition to Issuer	−13.4K sh	—	—	0
2023-09-01	NUVASIVE INCD Disposition to Issuer	EVP and CFO	DDisposition to Issuer	−11.1K sh	—	—	0
2023-09-01	NUVASIVE INCRestricted Stock UnitD Disposition to Issuer	EVP and CFO	DDisposition to Issuer	−13.4K sh	—	—	0
2023-09-01	NUVASIVE INCRestricted Stock UnitD Disposition to Issuer	EVP and CFO	DDisposition to Issuer	−37.5K sh	—	—	0
2023-09-01	NUVASIVE INCRestricted Stock UnitD Disposition to Issuer	EVP and CFO	DDisposition to Issuer	−14.7K sh	—	—	0
2023-03-01	NUVASIVE INCRSUsM Exercise/Conversion	EVP and CFO	MExercise/Conversion	−12.2K sh	—	—	0
2023-03-01	NUVASIVE INCRSUsA Award	EVP and CFO	AAward	+37.5K sh	—	—	37,498
2023-03-01	NUVASIVE INCM Exercise/Conversion	EVP and CFO	MExercise/Conversion	+12.2K sh	—	—	14,048
2023-03-01	NUVASIVE INCF Tax Payment	EVP and CFO	FTax Payment	−3,526 sh	$42.67	−$150K	10,522
2023-01-01	NUVASIVE INCRSUsM Exercise/Conversion	EVP and CFO	MExercise/Conversion	−1,286 sh	—	—	0
2023-01-01	NUVASIVE INCM Exercise/Conversion	EVP and CFO	MExercise/Conversion	+1,286 sh	—	—	2,298
2023-01-01	NUVASIVE INCF Tax Payment	EVP and CFO	FTax Payment	−440 sh	$41.24	−$18.1K	1,858
2022-03-01	NUVASIVE INCRSUsA Award	EVP and CFO	AAward	+14.7K sh	—	—	14,677
2021-03-01	NUVASIVE INCRSUsA Award	EVP and CFO	AAward	+13.4K sh	—	—	13,411
2020-03-02	NUVASIVE INCRSUsA Award	EVP and CFO	AAward	+12.2K sh	—	—	12,190
2020-01-02	NUVASIVE INCRSUsA Award	EVP and CFO	AAward	+1,286 sh	—	—	1,286
2019-04-02	Keenova Therapeutics plcF Tax Payment	EVP & President, Spec Gen	FTax Payment	−2,533 sh	$22.80	−$57.8K	104,115
2019-01-04	Keenova Therapeutics plcF Tax Payment	EVP & President, Spec Gen	FTax Payment	−656 sh	$17.21	−$11.3K	106,648
2019-01-03	Keenova Therapeutics plcF Tax Payment	EVP & President, Spec Gen	FTax Payment	−1,180 sh	$16.14	−$19K	107,304
2019-01-02	Keenova Therapeutics plcF Tax Payment	EVP & President, Spec Gen	FTax Payment	−341 sh	$16.59	−$5,657.19	108,484
2018-04-02	Keenova Therapeutics plcA Award	EVP & President, Spec Gen	AAward	+34.1K sh	—	—	108,121
2018-04-02	Keenova Therapeutics plcEmployee Share Options (Right to Buy)A Award	EVP & President, Spec Gen	AAward	+178K sh	—	—	177,849
2018-01-04	Keenova Therapeutics plcF Tax Payment	EVP & President, Spec Gen	FTax Payment	−838 sh	$23.40	−$19.6K	73,440
2018-01-03	Keenova Therapeutics plcF Tax Payment	EVP & President, Spec Gen	FTax Payment	−1,508 sh	$23.51	−$35.5K	74,278
2018-01-02	Keenova Therapeutics plcF Tax Payment	EVP & President, Spec Gen	FTax Payment	−1,610 sh	$23.52	−$37.9K	75,786
2018-01-02	Keenova Therapeutics plcA Award	EVP & President, Spec Gen	AAward	+2,404 sh	—	—	77,396
2017-07-01	Keenova Therapeutics plcF Tax Payment	EVP & President, Spec Gen	FTax Payment	−1,620 sh	$44.81	−$72.6K	74,668
2017-03-10	Keenova Therapeutics plcP Purchase	EVP & President, Spec Gen	PPurchase	+600 sh	$49.19	+$29.5K	76,085
2017-01-04	Keenova Therapeutics plcF Tax Payment	EVP & President, Spec Gen	FTax Payment	−724 sh	$53.19	−$38.5K	75,329
2017-01-03	Keenova Therapeutics plcA Award	EVP & President, Spec Gen	AAward	+1,718 sh	—	—	76,053
2017-01-03	Keenova Therapeutics plcEmployee Share Options (Right to Buy)A Award	EVP & President, Spec Gen	AAward	+63.4K sh	—	—	63,397
2017-01-03	Keenova Therapeutics plcEmployee Share Options (Right to Buy)A Award	EVP & President, Spec Gen	AAward	+74.7K sh	—	—	74,675
2017-01-03	Keenova Therapeutics plcA Award	EVP & President, Spec Gen	AAward	+13.3K sh	—	—	74,335
2017-01-02	Keenova Therapeutics plcA Award	EVP & President, Spec Gen	AAward	+10.9K sh	—	—	65,376
2017-01-02	Keenova Therapeutics plcF Tax Payment	EVP & President, Spec Gen	FTax Payment	−4,334 sh	$49.82	−$216K	61,042
2016-12-03	Keenova Therapeutics plcF Tax Payment	EVP & President, Spec Gen	FTax Payment	−297 sh	$53.61	−$15.9K	54,512
2016-07-01	Keenova Therapeutics plcF Tax Payment	EVP & President, Spec Gen	FTax Payment	−1,460 sh	$61.84	−$90.3K	54,618
2016-05-10	Keenova Therapeutics plcP Purchase	EVP & President, Spec Gen	PPurchase	+500 sh	$59.37	+$29.7K	56,036
2016-02-09	Keenova Therapeutics plcP Purchase	EVP & President, Spec Gen	PPurchase	+1,300 sh	$63.00	+$81.9K	55,383
2016-01-04	Keenova Therapeutics plcA Award	EVP & President, Spec Gen	AAward	+809 sh	—	—	54,010
2016-01-04	Keenova Therapeutics plcEmployee Share Options (Right to Buy)A Award	EVP & President, Spec Gen	AAward	+49.5K sh	—	—	49,508
2016-01-04	Keenova Therapeutics plcA Award	EVP & President, Spec Gen	AAward	+7,575 sh	—	—	53,201
2016-01-02	Keenova Therapeutics plcF Tax Payment	EVP & President, Spec Gen	FTax Payment	−669 sh	$74.63	−$49.9K	45,626
2015-12-04	Keenova Therapeutics plcP Purchase	EVP & President, Spec Gen	PPurchase	+240 sh	$73.54	+$17.6K	46,295
2015-12-03	Keenova Therapeutics plcP Purchase	EVP & President, Spec Gen	PPurchase	+260 sh	$74.05	+$19.3K	46,055
2015-12-03	Keenova Therapeutics plcF Tax Payment	EVP & President, Spec Gen	FTax Payment	−426 sh	$72.20	−$30.8K	45,795
2015-12-01	Keenova Therapeutics plcF Tax Payment	EVP & President, Spec Gen	FTax Payment	−1,009 sh	$71.48	−$72.1K	46,190

Recent filings

Accepted (ET)
Dec 54
Harbaugh Matthew K0001628280-25-055669
SEC(opens sec.gov)
Nov 44
Harbaugh Matthew K0001628280-25-049142
SEC(opens sec.gov)
Sep 54
Harbaugh Matthew K0001209191-23-048171
SEC(opens sec.gov)
Mar 34
Harbaugh Matthew K0001209191-23-015847
SEC(opens sec.gov)
Jan 34
Harbaugh Matthew K0001209191-23-000364
SEC(opens sec.gov)
Mar 34
Harbaugh Matthew K0001209191-22-015762
SEC(opens sec.gov)
Mar 34
Harbaugh Matthew K0001209191-21-017144
SEC(opens sec.gov)
Mar 34
Harbaugh Matthew K0001209191-20-015520
SEC(opens sec.gov)
Jan 34
Harbaugh Matthew K0001209191-20-001324
SEC(opens sec.gov)
Apr 34
Harbaugh Matthew K0000950138-19-000215
SEC(opens sec.gov)

Companies

Address

C/O MALLINCKRODT PLC 675 JAMES S. MCDONNELL BLVD.

HAZELWOOD, MO, 63042